Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
BMC Microbiology|March 19, 2016
Genotyping bacterial and fungal pathogens using sequence variation in the gene for the CCA-adding enzymePaul Franz, Heike Betat, Mario MörlInternational Journal of Molecular Sciences|January 16, 2020
Divergent Evolution of Eukaryotic CC- and A-Adding EnzymesLieselotte Erber, Paul Franz, Heike Betat, et al.Frontiers in Bioengineering and Biotechnology|December 25, 2025
"Live" cell shipment-a forward-looking transport option for cryo-sensitive cell-based therapiesLutz Roßbach, Thea Eichenberg, Nicole Pietzsch, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|February 26, 2025
A User-Centric Approach to Reliable Automated Flow Cytometry Data Analysis for Biomedical ApplicationsGeorg Popp, Lisa Jöckel, Michael Kläs, et al.Scientific Reports|October 24, 2023
Comparison of two lab-scale protocols for enhanced mRNA-based CAR-T cell generation and functionalityNadine von Auw, Robert Serfling, Reni Kitte, et al.Frontiers in Immunology|December 11, 2023
Accelerating development of engineered T cell therapies in the EU: current regulatory framework for studying multiple product versions and T2EVOLVE recommendationsDelphine Ammar, Inga Schapitz, Maik Luu, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2024
Optimizing CAR-T treatment: A T2EVOLVE guide to raw and starting material selectionSergio Navarro, Carole Moukheiber, Susana Inogés Sancho, et al.Frontiers in Immunology|May 9, 2025
European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoringBiagio De Angelis, Maria Luisa D'Amore, Pacôme Lecot, et al.Leukemia|January 6, 2024
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myelomaLuise Fischer, Nora Grieb, Patrick Born, et al.Nature Cancer|April 19, 2024
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myelomaMichael Rade, Nora Grieb, Ronald Weiss, et al.Pageof 2